NeueHealth, Inc. (NEUE)
(Delayed Data from NYSE)
$5.09 USD
+0.15 (2.94%)
Updated Nov 6, 2024 09:44 AM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
Price, Consensus and EPS Surprise
NEUE 5.09 +0.15(2.94%)
Will NEUE be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for NEUE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NEUE
Charles River Laboratories (CRL) Q3 Earnings and Revenues Beat Estimates
Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates
NEUE: What are Zacks experts saying now?
Zacks Private Portfolio Services
NeueHealth (NEUE) Upgraded to Buy: What Does It Mean for the Stock?
Other News for NEUE
NeueHealth Inc (NEUE) Q3 2024 Earnings Report Preview: What to Expect
NeueHealth buys full ownership of Centrum Health
NeueHealth acquires full ownership of Centrum Health
NeueHealth acquires full ownership of Centrum Health
NeueHealth Inc Completes Acquisition of Centrum Health